Acadia Up 14% After Q2 Beat

By: via Benzinga
Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) shares are trading higher by $4.20 at $33.74 in Wednesday's session. After the close on ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.